{"id":1181,"date":"2023-07-06T15:00:24","date_gmt":"2023-07-06T12:00:24","guid":{"rendered":"https:\/\/iwanhospital.com\/?page_id=1181"},"modified":"2025-11-06T16:03:24","modified_gmt":"2025-11-06T14:03:24","slug":"drhammad-en","status":"publish","type":"page","link":"https:\/\/iwanhospital.com\/?page_id=1181&lang=en","title":{"rendered":"Dr. Abdelrahman Hammad"},"content":{"rendered":"

[vc_row css=”.vc_custom_1682939429355{padding-bottom: 30px !important;}”][vc_column]

<\/div>

Dr. Abdelrahman Hammad<\/h2><\/div>
<\/p>\n

CEO<\/p>\n

<\/div><\/div>[vc_empty_space]

<\/div>[\/vc_column][\/vc_row][vc_row equal_height=”yes” type=”vc_default” el_class=”custom-columns-gap reverse-row-on-mobile” css=”.vc_custom_1683197016313{padding-top: 30px !important;background-color: #fefefe !important;}”][vc_column css_animation=”bounceInLeft” width=”1\/2″ offset=”vc_col-lg-6 vc_col-md-6 vc_col-xs-12″ css=”.vc_custom_1762436616704{padding-top: 0px !important;padding-right: 0px !important;padding-bottom: 0px !important;padding-left: 0px !important;}” el_id=”adult-syc”]
\t\t
<\/div><\/div>[vc_column_text css=”.vc_custom_1723290126285{margin-bottom: 22px !important;}”]<\/p>\n
\n
\n
    \n
  • Psychiatry and Addiction medicine expert, Opinion leader, researcher and writer with more than 18 years of experience in psychiatry and addiction medicine in both public and private sectors for mental health in Egypt. CEO at Iwan psychiatric hospital.
    \nCEO at Insight Institute for mental health and addiction medicine.<\/li>\n
  • Former head of addiction medicine department at Abbasia mental health hospital, General Secretariat of mental health and addiction medicine, ministry of health and population, Arab republic of Egypt.<\/li>\n<\/ul>\n<\/div>\n
      \n
    • Participated in the preparation and publication of three research papers that were published in international conferences:<\/li>\n
    • \n
        \n
      • National drug facts week campaign in Egypt in collaboration with NIDA<\/li>\n
      • A probable stimulant use disorder and withdrawal syndrome linked to Modafinil: A case report – European Psychiatric Association – EPA, in its annual international conference held in Poland.<\/li>\n
      • From a potential treatment to probable harm: A case series of Pregabalin withdrawal syndrome \u2013 American Psychiatric Association \u2013 APA<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<\/div>\n

        [\/vc_column_text]\t\t<\/div><\/div>[\/vc_column][vc_column css_animation=”bounceInRight” width=”1\/2″ offset=”vc_col-lg-6 vc_col-md-6 vc_col-xs-12″]